Early Stage Mentoring
Resources
Early-Stage Mentoring

Early-Stage Mentoring
So you’ve got an idea for a biotech or biopharma technology that can change the world, make people’s lives better. You have preliminary data. What now? How do you get on the road to commercialization? How can you set yourself up for success? Mentorship is the answer. We can connect you to mentors who have decades of experience in life science, having founded, led and invested in multiple companies. They’re grateful for what they’ve achieved. They want to give back by helping you.
“I should have sought out people who had been down the road before.”
— UC Berkeley professor & Nobel laureate Jennifer Doudna, on the one thing she would have changed about her experience commercializing CRISPR
Our deadlines in 2025 are February 14, May 30, and October 10.
Our goals for this elite program
QB3 and Bakar Bio Labs, the incubator that we operate in partnership with UC Berkeley, both serve entrepreneurs translating new technology to solve the most important problems facing society. Through this program, we offer training for entrepreneurs, and hope to generate high-quality tenant companies for our incubator. But if your company decides another space is better, we’ll be just as happy to have helped you advance your technology!
Why you want this
Expert guidance
We’ll match you with experienced mentors who can advise you on:
- Technology-market fit: Where can your discovery or invention be most profitably employed and generate the most benefit to society.
- How to separate your commercial and academic work.
- How to handle your intellectual property: patents and more. (Mentors will sign CDAs).
- How to develop your fundraising strategy.
- How to plot the quickest path to an IND or 510(k) approval.
Welcome to Our Community
- Concierge service. You’ll get invitations to all in-person speakers, showcases, and networking events at Bakar Bio Labs.
- You’ll have fun connecting with and learning from your peers and the mentor group.
- We arrange group meetings so you can get answers to your questions about IP law, financing, investing, and more.
Potential for Funding
- You’ll get exposure to our affiliated venture firm BEVC.
- Mentors will nominate select candidates to pitch for for $100K proof-of-concept support. This could take the form of a grant to a UC academic lab, or in-kind support to an incorporated company: $100K worth of rent at Bakar Bio Labs, in exchange for a SAFE note. (This is contingent on acceptance to the incubator.)
What it costs
There is no fee for the program.
It is anticipated that after a 3-month trial period, if the entrepreneur-mentor relationship is productive, a mentor will begin to receive equity in the company as a consultant. Amount: If pre-incorporation, none. If recently incorporated, 1% to vest over months 4-6 of the program. If seed funded, 0.5%. If Series A funded, 0.25%.
Eligibility
- Pre-incorporation or recently incorporated company commercializing biotech with a wet-lab component.
- More than just a concept. Initial data in hand.
- Based in California, or intending to move here soon.
- No university affiliation required.
How it works
If you meet the criteria above, please scroll down to apply. Our team will assess your technology and connect you to a mentor or mentors with experience in your field. We assess applications and assign mentors three times a year.
You’ll work with the mentors directly. We can reserve meeting space at the Bakar Bio Labs incubator on the UC Berkeley campus.
Our deadlines in 2025 are February 14, May 30, and October 10.
Companies in the program
Q4 2024
Ciznor
DiscoDisc Bio
Q2 2023
KuriBio
HPI Bio
Olfa Thera
ReCreate Bio
Q3 2023
Omni Tx
Opus Bio
Q4 2023
Sprint Synthesis
Q1 2024
Sphinxion
Tipping Point
Vertility
Mentor Board
Brian Atwood
Managing Director, Versant Ventures
Jamie Bacher
agriculture biotech, industrial biotech, synthetic biology
Fay Christodoulou
CSO Microfluidics, Integra Biosciences
Philippe Cronet
General Manager, Wacker Biotech USA
Ameena El-Bibany
Life Science Investor
Colin Farlow
Head of Serotiny
Justin Farlow
Head of Serotiny, R&D
Xue Snow Ge
VP, Clinical Pharmacology, BridgeBio
Randal Goomer
Principal AI/ML HealthCare & Life Sciences, Amazon Web Services
Jane Grogan
Head of Research, Biogen
Mandana Honu
Biotech BD & Strategy Executive
John Hoekman
CSO & Founder, Impel NeuroPharma
Melissa Kotterman
Former CSO, Iris Medicine Co-Founder, 4D Molecular & IGNITE Immunotherapy
Manfred Lee
COO, Mirvie
Jennifer Leeds
Retired from Novartis
Xiaole Shirley Liu
Co-Founder & CEO, GV20 Therapeutics
Nadja Mannowetz
Co-Founder & CSO, YourChoice Therapeutics
Widya Mulyasasmita
Managing Partner, BEVC
George Rehm
Director, Artera.AI
Ben Sun
Advisor, Berkeley SkyDeck
Mickey Urdea
Founder & Partner, Halteres Associates
Jimmy Zhang
Founder, Former Chairman & CEO, AccuGen Group; Former VP Transactions, J&J
Carolyne Zimmermann
CBO, SonoThera